DÄ internationalArchiveReferences
References

Original article

Potentially Inappropriate Medications in the Elderly

Dtsch Arztebl Int 2010; 107(31-32): 543-51. DOI: 10.3238/arztebl.2010.0543

Holt, S; Schmiedl, S; Thürmann, P A

1.Akker M vd, Buntinx F, Knottnerus A: Comorbidity or multimorbidity: what’s in a name? A review of the literature. Eur J Gen Pract 1996; 2: 65–70.
2.Coca V, Nink K: Arzneimittelverordnungen nach Alter und Geschlecht. In: Schwabe U, Paffrath D (eds.): Arzneiverordnungsreport 2009. Heidelberg: Springer Medizin Verlag 2009; 901–14.
3.Milton JC, Hill-Smith I, Jackson SHD: Prescribing for older people. BMJ 2008; 336: 606–9. MEDLINE
4.Mangoni AA, Jackson SHD: Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2003; 57: 6–14. MEDLINE
5.Laroche ML, Charmes JP, Bouthier F, Merle L: Inappropriate medications in the elderly. Clin Pharmacol Ther 2009; 85: 94–7. MEDLINE
6.Beers MH: Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 1997; 157: 1531–6. MEDLINE
7.Fick DM, Cooper JW, Wade WE, Waller JL, Maclean R, Beers MH: Updating the Beers criteria for potentially inappropriate medication use in older adults. Results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716–24. MEDLINE
8.McLeod PJ, Huang A, Tamblyn RM, Gayton DC: Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 1997; 156: 385–91. MEDLINE
9.Laroche ML, Charmes JP, Merle L: Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007; 63: 725–31. MEDLINE
10.Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D: STOPP (Screening Tool of Older Person’s Prescription) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72–83. MEDLINE
11.Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J: The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care 2009; 27: 153–9. MEDLINE
12.Jano E, Aparasu RR: Healthcare outcomes associated with Beers’ Criteria: a systematic review. Ann Pharmacother 2007; 41: 438–48. MEDLINE
13.Jones J, Hunter D: Consensus methods for medical and health services research. BMJ 1995; 311: 376–80. MEDLINE
14.Fialová D, Topinková E, Gambassi G, et al.: Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293: 1348–58. MEDLINE
15.Spinewine A, Schmader KE, Barber N, et al.: Prescribing in elderly people 1—Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370: 173–84. MEDLINE
16.Hanlon JT, Schmader KE, Ruby CM, Weingerber M: Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200–9. MEDLINE
17.Junius U, Schultz C, Fischer G: Evidenz-basiertes präventives Assessment für betagte Patienten. Z Allg Med 2003; 79: 143–8.
e1.Statistisches Bundesamt: Bevölkerung Deutschlands bis 2060. 12. koordinierte Bevölkerungsvorausberechnung. Wiesbaden 2009; page 5; letzter Zugriff 05.07.2010.
e2.Lernfelt B, Samuelsson O, Skoog I, Landahl S: Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol 2003; 59: 637–44. MEDLINE
e3.Griens AMGF, Tinke JL, van der Vaart RJ: Facts and figures 2008. Foundation for pharmaceutical statistics (Stichting Farmaceutische Kengetallen), August 2008; letzter Zugriff 05.07.2010.
e4.Gallagher P, Barry P, O’Mahony D: Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007; 32: 113–21. MEDLINE
e5.National Center for Health Statistics: Health, United States 2008. With Chartbook Hyattsville, MD: 2009; letzter Zugriff 05.07.2010.
e6.Thürmann PA, Werner U, Hanke F, et al.: Arzneimittelrisiken bei hochbetagten Patienten: Ergebnisse deutscher Studien. In (ed. BÄK): Fortschritt und Fortbildung in der Medizin. Band 31. Köln: Deutscher Ärzte-Verlag Band 31; 2007: 216–24.
e7.Onder G, Pedone C, Landi F, et al.: Adverse drug reactions as cause of hospital admissions: results from the Italian group of pharmacoepidemiology in the elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962–8. MEDLINE
e8.Turnheim K: When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003; 38: 843–53. MEDLINE
e9.Turnheim K: Drug therapy in the elderly. Exp Gerontol 2004; 39: 1731–8. MEDLINE
e10.Berdot S, Bertrand M, Dartigues JF, et al.: Inappropriate medication use and risk of falls—A prospective study in a large community-dwelling elderly cohort. BMC Geriatrics 2009; 9: 30. MEDLINE
e11.Bundesministerium für Gesundheit: Aktionsplan 2008/2009 zur Verbesserung der Arznei­mittel­therapie­sicherheit. 2007; page 26; letzter Zugriff 05.07.2010.
e12.Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen: Koordination und Integration – Gesundheitsversorgung in einer Gesellschaft des längeren Lebens. Sondergutachten 2009; page 476–8; letzter Zugriff 05.07.2010.
e13.Schwabe U, Paffrath D (eds.): Arzneiverordnungsreport 2008 – Aktuelle Daten, Kosten, Trends und Kommentare. Heidelberg: Springer Medizin Verlag 2008.
e14.Dalkey NC: The Delphi method: an experimental study of a group opinion. Rand Corporation, Santa Monica, RM–5888-PR; 1969.
e15.Häder M: Delphi-Befragungen – ein Arbeitsbuch. 1st edition. Wiesbaden: Westdeutscher Verlag 2002.
e16.Matell MS, Jacoby J: Is there an optimal number of alternatives for Likert scale items? I: reliability and validity. Educ Psychiol Measure 1971; 31: 657–74.
e17.Fachinformation Efient, Eli Lilly – DAIICHI-SANKYO DEUTSCHLAND GmbH, Stand September 2009. http://www.fachinfo.de
e18.Micromedex Healthcare Series. Internet database: Greenwood Village, Colo: Thomson Reuters (Healthcare) Inc. Updated periodically. http://www.thomsonhc.com/home/dispatch; letzer Zugriff: 05.07.2010.
e19.Hamilton HJ, Gallagher PF, O’Mahony D: Inappropriate prescribing and adverse drug avents in older people. BMC Geriatrics 2009; 9: 5. MEDLINE
e20.Steinman MA, Rosenthal GE, Landefeld CS, Bertenthal D, Kaboli PJ: Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing. Arch Intern Med 2009; 169: 1326–32. MEDLINE
e21.Leitliniengruppe Hessen (Bergert FW, Braun M, Clarius H, et al.): Hausärztliche Leitlinie Geriatrie. Part 1 and 2. Version 1.0 2008;
letzter Zugriff 05.07.2010.
e22.Feinstein AR, Horwitz RI: Problems in the „Evidence“ of „Evidence-based Medicine“. Am J Med 1997; 103: 529–35. MEDLINE
e23.Shi S, Mörike K, Klotz U: The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 2008; 64: 183–99. MEDLINE
e24.Stefanacci RG, Cavallaro E, Beers MH, Fick DM: Developing explicit positive Beers criteria for preferred central nervous system medications in older adults. Consult Pharm 2009; 24: 601–10. MEDLINE
e25.Fachinformation Cordichin, Abbott GmbH & Co. KG, Stand November 2008. http://www.fachinfo.de
e26.Wilson K, Mottram P: A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis. Int J Geriatr Psychiatry 2004; 19: 754–62. MEDLINE
e27.Pollock BG: Adverse reactions of antidepressants in elderly patients. J Clin Psychiatry 1999; 60 Suppl 20: 4–8. MEDLINE
e28.Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ 3rd: Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363–9. MEDLINE
e29.Blazer DG 2nd, Federspiel CF, Ray WA, Schaffner W, et al.: The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. J Gerontol 1983; 38: 31–5. MEDLINE
e30.Fachinformation Amitriptylin-Sandoz 100 mg Retardtablette, Sandoz Pharmaceuticals GmbH, Stand März 2007. http://www.fachinfo.de
e31.Cohn CK, Shrivastava R, Mendels J, et al: Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry. 1990; 51 Suppl B: 28–33. MEDLINE
e32.Davies RK, Tucker GL, Harrow M et al.: Confusional episodes and antidepressant medication. Am J Psychiatry 1971a; 128: 127. MEDLINE
e33.Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling A-K, Avorn J: Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002; 58: 285–91. MEDLINE
e34.Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS: Evidence based medicine: what it is and what it isn’t. BMJ 1996; 312: 71–2. MEDLINE
e35.Guyatt G: Evidence-based medicine [editorial]. ACP J Club 1991; 114: A-16.